GENE ONLINE|News &
Opinion
Blog

2025-12-01|

Study Examines Influence of Gonadal Hormones on Alzheimer’s Progression Using 3×Tg-AD Mouse Model

by GOAI
Share To

A recent study published in the journal *Biology of Sex Differences* has examined the role of gonadal hormones in influencing Alzheimer’s disease, with a focus on gender differences. Researchers conducted their investigation using the 3×Tg-AD mouse model, a widely accepted model for studying human Alzheimer’s pathology. The findings provide new insights into how sex hormones may impact the progression and characteristics of Alzheimer’s disease.

The study explored how variations in gonadal hormone levels affect the development of Alzheimer’s-related symptoms in male and female mice. Researchers utilized this specific mouse model to analyze differences in brain pathology, cognitive function, and other markers associated with the disease. The results highlight potential biological mechanisms that could explain why men and women experience Alzheimer’s differently, though further research is necessary to determine how these findings translate to humans.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: December 1, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
LATEST
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
Janux Therapeutics Shares Halve Despite Positive Phase I Trial Results for Solid Tumor Therapy
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
2025-12-04
2025 Healthcare+ Expo Taiwan
Taipei, Taiwan
Scroll to Top